Performance evaluation of four dominant anti-hepatitis B core antigen (HBcAb) kits in Japan for preventing de novo hepatitis B virus (HBV) infection.
Authors:
- Eiji KobayashiEKEiji Kobayashi
- Matsuo DeguchiMDMatsuo Deguchi
- Masanori KagitaMKMasanori Kagita
- Nori YoshiokaNYNori Yoshioka
- Mifumi KitaMKMifumi Kita
- Seishi AsariSASeishi Asari
- Etsuji SuehisaESEtsuji Suehisa
- Yoh HidakaYHYoh Hidaka
- Yoshinori IwataniYIYoshinori Iwatani